Rare anaphylactic event following vaccination. May contain traces of egg protein. Caution in individuals w/ history of anaphylactic, anaphylactoid, or other immediate reactions subsequent to egg ingestion; history or family history of allergic disease or convulsions. Do not administer intravascularly. Postpone vaccination in case of acute severe febrile illness. Allow alcohol & other disinfecting agents to evaporate from the skin before inj since they can inactivate the attenuated viruses in the vaccine. Limited protection against measles may be obtained by vaccination up to 72 hr after exposure to natural measles. Protective immune response may not be elicited in all vaccinees. Reports of worsening & recurrence of thrombocytopenia in patients who suffered from thrombocytopenia after the 1st dose. Carefully monitor immunocompromised subjects for signs of MMR. Lactation. Infants <12 mth of age may not respond sufficiently to the measles component of the vaccine due to the possible persistence of maternal measles Abs. Consider revaccination at or after 12 mth of age.